Insulin Lispro-aabc Injection — FDA Drug Shortage

No longer listed by FDA — Eli Lilly And Co.

The FDA lists a drug shortage record for Insulin Lispro-aabc Injection (injection) from Eli Lilly And Co. with status No longer listed by FDA. The shortage was first posted on Oct 24, 2025.

Shortage details

Status
No longer listed by FDA
Company
Eli Lilly And Co.
Package NDC
0002-8235-05
Dosage Form
Injection
Presentation
Lyumjev, Injection, U-100 Tempo Pen (NDC 0002-8235-05)
Initial Posting
Oct 24, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.